MiRNAs in Aging and Cancer: Volume 334

MiRNAs in Aging and Cancer: Volume 334

Volume editor  , Volume editor 

Free delivery worldwide

Available. Dispatched from the UK in 1 business day
When will my order arrive?


MiRNAs in Aging and Cancer, Volume 334, the latest in the International Review of Cell and Molecular Biology series, reviews and details current advances in cell and molecular biology. This new release includes chapters on a variety of timely topics, including the Regulation of autophagy by miRNAs, the Impact of miRNAs in cellular senescence, miRNAs in hematopoiesis, stem cell biology and hematological disorders, the Impact of miRNAs on longevity, miRNA deregulation in cardiovascular aging and associated disorders, miRNA deregulation in aging-associated pathologies of the skeletal muscle, and miRNAs and neurodegeneration.

The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists. The articles published in IRCMB have a high impact and an average cited half-life of 9 years. This great resource ranks high amongst scientific journals dealing with cell biology.
show more

Out of ideas for the holidays?

Visit our Gift Guides and find our recommendations on what to get friends and family during the holiday season. Shop now .

Product details

  • Hardback | 354 pages
  • 152 x 229 x 19.05mm | 750g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0128118687
  • 9780128118689

Table of contents

1. Regulation of autophagy by miRNAs

Hongming Pan

2. Impact of miRNAs in cellular senescence

Frederick Antoine Mallette

3. miRNAs in hematopoiesis, stem cell biology and hematological disorders

Keisuke Ito

4. Impact of miRNAs on longevity

Kotb Abdelmohsen

5. miRNA deregulation in cardiovascular aging and associated disorders

Blanche Schroen

6. miRNA deregulation in aging-associated pathologies of the skeletal muscle

Katarzyna Goljanek-Whysall

7. miRNAs and neurodegeneration

Eva Jimenez-Mateos
show more

About Lorenzo Galluzzi

Lorenzo Galluzzi (born 1980) is currently Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College (New York, USA), and Honorary Associate Professor at the Faculty of Medicine of the Paris Descartes University (Paris, France).

Prior to joining Weill Cornell Medical College (2017), Lorenzo Galluzzi was a Junior Scientist of the Research Team "Apoptosis, Cancer and Immunity" at the Cordeliers Research Center (Paris, France; 2012-2016). Lorenzo Galluzzi did his post-doctoral training at the Gustave Roussy Cancer Center (Villejuif, France; 2009-2011), after receiving his PhD from the Paris Sud University (Le Kremlin-Bicetre, France; 2005-2008). He is also Associate Director of the European Academy for Tumor Immunology (EATI), and Founding Member of the European Research Institute for Integrated Cellular Pathology (ERI-ICP).

Lorenzo Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. In particular, he provided profound insights into the links between adaptive stress responses in cancer cells and the activation of a clinically relevant tumor-targeting immune response in the context of chemotherapy and radiation therapy. Lorenzo Galluzzi has published more than 350 scientific articles in international peer-reviewed journals. According to a survey published by Lab Times, he is currently the 6th and the youngest of the 30 most-cited European cell biologists (relative to the period 2007-2013).

Lorenzo Galluzzi currently operates as Editor-in-Chief of three journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, and Molecular and Cellular Oncology (which he co-founded in 2013). In addition, Lorenzo Galluzzi currently serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease. Dr Ilio Vitale is an esteemed oncologist. He is a member of the University of Rome and associated to the Regina Elena National Cancer Institute based in Italy.
show more